LeaderSource Limited – Trademark Portfolio
Entity Type: 03
LeaderSource Limited has 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include THE PAUSE PRINCIPLE and EXECUTIVE TO LEADER INSTITUTE. The portfolio includes 2 registered trademarks. Filings span 3 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 42 (Computer & Scientific). This trademark owner is based in Minneapolis, MD.
Suite 2600
120 South Sixth Street
Minneapolis, MD 55402
Showing of trademarks Trademarks
Trademark Classifications
LeaderSource Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does LeaderSource Limited have?
LeaderSource Limited has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 8 cancelled.
What trademark classes does LeaderSource Limited file in?
LeaderSource Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are LeaderSource Limited's most well-known trademarks?
LeaderSource Limited's registered trademark portfolio includes well-known marks such as THE PAUSE PRINCIPLE and EXECUTIVE TO LEADER INSTITUTE. These are among 2 currently registered trademarks in the portfolio.
What is LeaderSource Limited's trademark registration success rate?
LeaderSource Limited has a 18% trademark registration rate, with 2 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.